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Introduction: Hypoxemia and high fractions of inspired oxygen (FiO2) are concerns in critically ill patients. An
automated FiO2 controller based on continuous oxygen saturation (SpO2) measurement was tested. Two different
SpO2-FiO2 feedback open loops, designed to react differently based on the level of hypoxemia, were compared.
The results of the FiO2 controller were also compared with a historical control group.
Methods: The system measures SpO2, compares with a target range (92% to 96%), and proposes in real time FiO2
settings to maintain SpO2 within target. In 20 patients under mechanical ventilation, two different FiO2-SpO2 open
loops were applied by a dedicated research nurse during 3 hours, each in random order. The times spent in and
outside the target SpO2 values were measured. The results of the automatic controller were then compared with
a retrospective control group of 30 ICU patients. SpO2-FiO2 values of the control group were collected over three
different periods of 6 hours.
Results: Time in the target range was higher than 95% with the controller. When the 20 patients were separated
according to the median PaO2/FiO2 (160(133-176) mm Hg versus 239(201-285)), the loop with the highest slope was
slightly better (P = 0.047) for the more-hypoxemic patients. Hyperoxemia and hypoxemia durations were significantly
shorter with the controller compared with usual care: SpO2 target range was reached 90% versus 24%, 27% and 32%
(P < .001) with the controller, compared with three historical control-group periods.
Conclusion: A specific FiO2 controller is able to maintain SpO2 reliably within a predefined target range. Two different
feedback loops can be used, depending on the initial PaO2/FiO2; with both, the automatic controller showed excellent
performance when compared with usual care.Introduction
Oxygen is essential for life. As has any drug, it has con-
sequences in case of under- and overdosing. In adult
intensive care patients, hypoxemia is a primary preoccu-
pation for all clinicians. The consequences of hyperoxemia
are more often neglected because they have been poorly
explored. Several clinical observations have suggested
that liberal administration of oxygen can be toxic [1-3].
Hyperoxia induces the constitution of free oxygen radicals
that may cause endothelial cell injury and increases the* Correspondence: Brochardl@smh.ca
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reproduction in any medium, provided the orpresence of inflammatory cells [4]. It can lead to absorption
atelectasis in lung regions with low ventilation-to-perfusion
ratios [5]. In adult intensive care patients, it has been shown
that exposure to hyperoxemia may be harmful in specific
populations. In post-cardiac arrest patients, arterial hyper-
oxemia was independently associated with in-hospital
mortality, to an extent comparable to hypoxemia [6]. In
nonventilated severe COPD patients with exacerbation,
high FiO2 can be responsible for hypercapnia but also
increased mortality [7]. In patients with severe traumatic
brain injury, hyperoxemia is associated with increased
mortality and worse outcomes [8].
Based on these concerns and the possibility that optimiz-
ing oxygenation targets may improve patients’ outcome,
systems for automatic adjustment of FiO2 based on SpO2
measurement might be of great value to optimize care.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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several attempts have been made to automate the adjust-
ment of FiO2, especially in neonatology, because of the
frequent and unpredictable change of oxygenation and
risks of hyperoxemia in premature babies [9-12]. In adults,
preliminary attempts at closed-loop control of oxygenation
were developed and used in military trauma patients, as
well as for titrating the FiO2 for COPD patients requiring
long-term oxygen therapy [13-15]. These systems proved
a reduction in oxygen use without inducing hypoxemia
compared with conventional adjustments. Recently, an
automated oxygen-flow titration was tested on healthy
subjects during induced hypoxemia and showed a signifi-
cant reduction of hypoxemia and hyperoxemia compared
with classic constant-flow oxygen administration [16].
Last, a recent mode of ventilation allows full control of
both pressure-targeted breaths and the level of FiO2 in a
closed-loop manner. Two recent clinical studies showed
the feasibility of this technique [17,18].
To overcome the challenges of continuously maintain-
ing an adequate oxygenation in adult ICU patients, we
developed an automated oxygen-controller prototype that
aims to maintain the measured SpO2 in a predefined
target range [92% to 96%]. For this system, we defined two
different FiO2-SpO2 feedback profiles with the hypothesis
that the more-severely hypoxemic patients, because of
intrapulmonary shunt, are less sensitive to FiO2 changes
and need larger changes in FiO2 than do less-hypoxemic
patients. The first aim of the current study was to test
and compare these two different SpO2-FiO2 profiles in
patients with different degrees of hypoxemia to maintain
SpO2 in the predefined target range [92% to 96%]. To
evaluate the clinical impact of the system, we also com-
pared the results obtained with these two profiles of the
FiO2 controller with usual care based on a comparable
historical control group.
Materials and methods
Study design and patients
The study was conducted in the medical-surgical ICU of
Geneva University Hospital. The first part of the study
was a prospective trial performed in 20 ICU patients,
and the second part included a retrospective analysis of
consecutive admitted patients between September and
October 2011 in the same ICU. The two parts of the study
were accepted by the Ethics Committee of the hospital
[The Ethic Committee and Research on Human Beings
(CEREH), research project number 12089(NAC12040)].
For the first part, signed informed consents were ob-
tained from the patient when possible or from the family,
and from the attending physician. For both parts, inclusion
criteria were similar and mechanically ventilated patients
for more than 48 hours after ICU admission older than
18 years old. Patients with severe acidosis (pH ≤7.20),hemodynamic instability, serum lactate > 3mmol/L, or need
for norepinephrine infusion ≥0.5 μg/kg/min, pregnant, or
with intracranial hypertension were not included. Concern-
ing the second part, SpO2 had to be recorded continuously
to ensure the selection of the patient for the control group.
The automated FiO2 controller
The FIO2-controller prototype tested in the present study
included software implemented in a medical PC connected
via RS-232 serial links to a ventilator (Evita XL; Dräger
Medical, Lübeck, Germany) and to a pulse oximeter
(Radical 7; Masimo Corp, Irvine, CA, USA) set at an
averaging interval of 2 seconds. A probe was placed on
the finger of the patient while we used an ear probe in
case of poor perfusion, as indicated by the perfusion
index of the Masimo. The perfusion index (PI) which is
the ratio of the pulsatile blood flow to the nonpulsatile or
static blood in peripheral tissue, was calculated continu-
ously by the Masimo. A threshold of low signal and unreli-
able measurement was defined as signal index quality
(SIQ) <0.30, where the latter represents Masimo’s quality
indicator in case of extremely low perfusion and motion
conditions [19]. When SIQ was <0.30, the FiO2 controller
kept the last FiO2 before this low SIQ value.
The serial link connected to the pulse oximeter allowed
a continuous recording of SpO2 values, as well as heart
rate, perfusion index, SIQ, and SpO2 alarms every second.
With the same frequency, FiO2 values measured on the in-
spiratory nozzle and set on the ventilator were acquired
from the ventilator. The proposed FiO2 adjustments were
indicated by an acoustic signal and displayed on the screen
of the medical PC every 30 seconds. The purpose of the
present study was to test the reliability of the system
working in an open loop. To achieve this goal, a fully
dedicated ICU research nurse executed the adjustments
on the ventilator. He could deviate from any proposal if it
was considered to be unsafe, according to his clinical
judgment.
The target for the controller is the midpoint between
the high (96%) and low (92%) SpO2 targets (that is, 94%).
The automatic FiO2 controller compares the measured
SpO2 with the target 94% and calculates the difference to
control the delivered FiO2 set to the patient.
The delivered FiO2 depends on the selected version of
the algorithm. These latter are two tables that define
for each SpO2 deviations (ΔSpO2) an FiO2 step change
(either increase or decrease) to be applied to the current
FiO2. These two different tables define the two slopes of
SpO2-FiO2 tested in this study. The difference is based on
the fact that we hypothesized that, for severely hypoxemic
patients, a larger change or step in FiO2 is required than
for less-hypoxemic patients because intrapulmonary shunt
makes those patients less “sensitive” to FiO2 changes.
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to expire before changing FiO2 is allowed. To react imme-
diately in case of a severe hypoxemic event, the controller
applies 100% of FiO2 when SpO2 <85%. This reaction is the
same in the two versions of the algorithm.
For avoiding instabilities (that is, oscillations, overshoots),
the reaction of the FiO2 controller is dampened based on
physiological and technical delays. Because of this dampen-
ing of the controller, early adjustments every 30 seconds
were possible. The controller is based on a conventional
Proportional-Integral-Derivative (PID) control using both
the SpO2-FiO2 slopes and ΔFiO2 step changes, based on
an estimated effective FiO2.
Study protocol
The study was composed of two parts: a prospective trial
and a retrospective analysis.
First part, prospective trial
The first part of the study consisted of a prospective
crossover trial that aimed to compare the usefulness of
two feedback open-loop profiles for the FiO2 controller.
The trial corresponded to two 3-hour periods applied
in randomized order, with FiO2 adjusted according to
each profile by a research nurse. As the main difference
between the two profiles is the SpO2/FiO2 slope, we
tested the clinical difference of using these two differ-
ent slopes. During all study periods, the SpO2 target
range was 92% to 96%. This range was consistent with
previous clinical publications on automatic FiO2 controllers
[13,14,16,20]. It was considered a reasonable compromise
that combines safety (limiting risk of hypoxemia) and
efficacy to limit FiO2 in comparison to usual care, and
which was also used in the control ICU. This was import-
ant for the comparison between the two groups in the
study (study group and historical control group). A research
nurse was fully dedicated for the FiO2 adjustments and
remained at the bedside during each trial. Meanwhile,
patients continued to receive usual care and ventilator
parameters such as positive end-expiratory pressure (PEEP),
were kept constant unless the clinician asked for changes.
In two patients, a change of PEEP was required.
All patients were ventilated with the same ventilator
(Evita XL) and were randomly allocated to an order for
the two profiles by opening a sealed envelope. During
the recordings, endotracheal suctioning could be needed.
Before any suctioning, FiO2 was increased to 100%.
This was obtained automatically in the first five patients
(preoxygenation procedure function of the ventilator).
However, this approach was not consistently used by
the nurses because it was not a systematic standard
approach for all patients. Therefore, we decided to
recommend doing it manually in the 15 other patients,
with FiO2 subsequently decreased by following theFiO2 controller suggestions. These episodes produced
major changes in FiO2 and SpO2 (especially in the high
range) over a short period, introducing noise in the sig-
nal and reducing the sensitivity of the comparison. We
decided against keeping it in the comparison because
we were expecting only small changes between the two
profiles. We therefore removed for the comparison of
the two profiles a period of 15 minutes for each episode
of suctioning (it usually took between 5 and 10 minutes
to come back to the preceding level) corresponding to
the preoxygenation and suctioning maneuvers.
For each patient, we selected the blood gases and venti-
lation parameters measured at baseline (in the morning).
The 20 patients were separated into two groups of 10 ac-
cording to the median PaO2/FiO2 ratio: a moderately
hypoxemic group with PF >188 mm Hg and a severely
hypoxemic group with PF ≤188 mm Hg.
Second part
The second part of the study consisted of a retrospective
data collection of an historical group composed of 30
patients admitted in the ICU before the start of the clinical
protocol and ventilated at least 48 hours. The nurse:pa-
tient ratio during this period was 1:1 or 1:2, depending
on the severity of the patient’s condition. Concerning
FiO2 adjustments in the ICU, no explicit limitations
were placed on the usual care, except a prescribed low
SpO2 threshold for all patients. Thus, FiO2 settings in
the historical control group were dependent on the
physician or nurse in charge and could be reduced to
21% if necessary. Data were collected from a patient
data-management system (Centricity Critical Care Clini-
soft GE Healthcare) over three different periods of 6 hours
(at admission, after 24 hours, at day 7). In this group,
SpO2 values were recorded every 1 to 2 minutes. We were
especially interested to the data obtained after 24 hours
and at day 7, because our patients in the first part were
studied after several days of mechanical ventilation. Pa-
tients’ identifying information was removed to keep them
completely anonymous. In this control group, a sub-
group of 17 patients had a minimal clinical threshold of
SpO2 ≥92% specifically ordered by the clinician until the
day 7 after admission; this subgroup was also compared
with the FiO2 controller because the latter has the same
low threshold for SpO2.
We could not precisely identify the suctioning periods in
the control group, and therefore, for this analysis, suction-
ing maneuvers, and preoxygenation periods were kept in
both groups (study group and the historical control group)
for the analysis. For the control group, SpO2 was measured
with a pulse-oximetry system (Intellivue MP70 monitor;
Philips Medical Systems, Amsterdam, The Netherlands).
SpO2 data recorded from the system contained very low
values, which carried a high probability of not being real.
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Masimo’s recordings, in which SpO2 values were almost
always ≥80%. We therefore defined aberrant values as
SpO2 <80% as corresponding to erroneous measurements
or artifacts, and we removed them from all the recordings
of this group.Patient data and analysis
For both groups, we collected the same baseline character-
istics including the Acute Physiology and Chronic Health
Evaluation (APACHE) II and the Simplified Acute Physi-
ology Score (SAPS) II at the day of admission. Blood gases
and care procedures were documented from nursing and
medical records. The first arterial blood gases at the day of
admission for the historical group and in the morning for
the study group were selected to define the baseline values
of pH, PaO2, PaCO2, SaO2, and to calculate the PaO2/
FiO2 ratio. Ventilator settings and modes in addition to
monitored measurements, including SpO2 and FiO2, were
recorded.
Times with SpO2 above, within, and below the target
range [92% to 96%] were reported as percentage of the
recorded time. These latter defined, respectively, hyper-
oxemia (SpO2 ≥97%), normoxemia (SpO2 ≥92% and
SpO2 ≤96%), and hypoxemia (SpO2 ≤91%). These per-
centages of time were used to compare the two profiles
in the first part of the study and to compare the FiO2
controller and the control groups in the second part.
The differences between the two slopes studied in the
first part of the study were considered small enough to
justify grouping together all data obtained with the
FiO2 controller. The percentage of time spent within
the target range was the primary outcome variable of
efficacy, and the percentage of time spent outside the
target was the outcome variable of safety.Statistical analysis
Statistical analysis was performed by using SPSS (SPSS
16.0; SPSS Inc, Chicago, IL, USA). Descriptive statistics
(median and 25th and 75th percentiles) were used to
summarize demographic characteristics and ventilation
and blood gases baseline values. SpO2 percentages were
presented as means with standard deviations. In the first
part of the study, a Mann-Whitney U test was used to
determine whether baseline characteristics (ventilation,
blood gases, scores) were significantly different between
the two groups of 10 patients separated on the median
value of the PaO2/FiO2 ratio. We performed pairwise
comparisons by using the Wilcoxon test to compare the
two profiles in each group. In the second part, a t test
was used to determine the significance of the difference
between the study group and the historical group.Results
First part
Patients
Twenty-two patients were enrolled in the study (sixteen
men and six women), and two patients could not
complete the study (the first one experienced self-
extubation after 2 hours of recordings, and the second
one’s condition was severely worsened before starting
the trial). All 20 patients tolerated the adjustments and
completed both tests. We classified the 20 included
patients into two categories of hypoxemia, according
to their median PaO2/FiO2 ratio. Table 1 describes the
characteristics of the two groups. They were compar-
able except for an older age in the moderately hypox-
emic patients. Table 2 shows ventilation parameters
and arterial blood gases. Tidal volume was higher and
FiO2 lower in the moderately hypoxemic patients. For
arterial blood gases, only oxygenation was significantly
different between the two groups (P < 0.001).
Hypoxemia, normoxemia, and hyperoxemia
Figure 1 shows an example of a patient’s recording: nor-
moxemia was maintained by the FiO2 controller during
98.0% of the recording time; hyperoxemia represented
2.0%, and hypoxemia, 0.1%. FiO2 set by the research nurse
and suggested by the FiO2 controller were continuously
recorded. More than 98% of the time, the research nurse
followed the FiO2-controller suggestions.
Table 3 compares the amount of time that patients
spent within and outside the target SpO2. Periods corre-
sponding to an absence of signal and when it was not
valid were also recorded. According to these criteria, we
compared the two profiles (slopes of response designed
for severely hypoxemic and moderately hypoxemic pa-
tients) in each group.
The percentage of time spent in the target range was
higher than 95% in all cases. The severely hypoxemic
profile was slightly better (P < 0.05) for the more-
hypoxemic patients (PaO2/FiO2 < 188) to keep them in
normoxemia. The number of suctioning episodes were
calculated in each group and reported in Additional file




Thirty patients were included in the analysis for the
control group. All patients were mechanically ventilated
within the first 24 hours after ICU admission. Data about
severity of illness, respiratory diagnosis, and demographic
characteristics are given in Additional file 2: Table S2.
A subgroup of 17 patients had a prescribed lower SpO2
threshold of 92% (that is, identical lower SpO2 threshold
than with the FiO2 controller), and was also analyzed
Table 1 Baseline characteristics of the patients
Variable Severe hypoxemia Moderate hypoxemia Ρ value
(n = 10) (n = 10)
Age, years 65 (49-69) 76 (72-83) 0.029
Sex, male/female 7/3 7/3
Height, cm 175 (171-183) 170 (161-177) 0.190
Weight, kg 71 (66-77) 66 (58-75) 0.315
Heart rate, beats per minute 88 (74-105) 84 (75-96) 0.393
APACHE II, at ICU admission 27 (24-30) 31 (26-33) 0.165
SAPS II, at ICU admission 53 (51-58) 56 (43-66) 0.684
SOFA, at day of recording 7 (7-9) 11 (9-13) 0.052
RASS, at day of recording −4 (-4 to -1) −1 (-3 to -1) 0.631
Mechanical ventilation, days 4 (2-7) 3 (1-5) 0.393
ICU stay, days 4 (2-7) 4 (1-8) 0.579
Respiratory diagnosis, n (%)
Pneumonia 3 (23) 1(10)
Acute pulmonary edema 1 (8) 0 (0)
COPD 4 (31) 2 (20)
ARDS 3 (23) 0 (0)
Other 2 (15) 7 (70)
Equipment, n
Endotracheal tube/tracheostomy 9/1 9/1
Diameter of the tube, mm 8.0 (7.5-8.0) 7.5 (7.5-8.0) 0.165
APACHE, Acute Physiology and Chronic Health Evaluation; ICU, intensive care unit; SAPS, Simplified Acute Physiology Score; RASS, Richmond Agitation Sedation
Scale. ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease. “Other” patients had cardiogenic shock (three), cardiac surgery,
spine surgery, cardiorespiratory arrest, or liver failure. One patient could be considered to have a normal lung.
Table 2 Ventilation and arterial blood gases of the patients
Variable Severe hypoxemia Moderate hypoxemia Ρ
value(n = 10) (n = 10)
Ventilator mode at study inclusion, n (%)
Pressure support ventilation 14 (70) 14 (70)
Pressure control ventilation 3 (15) 5 (25)
Volume assist control ventilation 2 (10) 1 (5)
Synchronized Intermittent Mandatory Ventilation 1 (5) 0 (0)
Ventilator settings (in the morning)
MV exp,vL 10 (10-12) 8 (7-10) 0.123
Tidal volume, ml/kg predicted body weight 7 (6-8) 9 (7-10) 0.011
Positive end-expiratory pressure, cm H2O 5 (5-7) 7 (5-8) 0.393
Peak inspiratory pressure, cm H2O 20 (17-25) 22 (18-25) 0.853
Inspired fraction of oxygen, % 40 (40-45) 30 (25-35) 0.001
Arterial blood gases (in the morning)
pH 7.45 (7.39-7.48) 7.40 (7.38-7.44) 0.247
PaO2, mm Hg 69 (63-71) 76 (72-79) 0.005
PaCO2, mm Hg 38 (35-54) 39 (35-42) 0.796
SaO2, % 94 (93-95) 97 (96-97) 0.001
PaO2/FiO2, mm Hg 160 (133-176) 239 (201-285) <0.001
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Figure 1 Example of a patient’s recording over a 3-hour period, displaying five signals respectively described from top to bottom:
SpO2 levels over time (blue line, bold); FiO2 steps set by the nurse (purple) and proposed by the FiO2 controller (red); at the bottom,
heart rate (grey) and perfusion index (purple) from Masimo. Please note that the grey circles indicate an example in which FiO2 set and FiO2
proposed were slightly divergent: this indicated a situation in which the nurse did not fully follow the FiO2-controller’s suggestions.
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Table S3 presents ventilation and blood gases for both
groups.
Group comparison
We compared the study group with the historical groups
to assess the efficiency of the FiO2 controller in main-
taining the SpO2 within the target range and reducing
time in hyperoxemia and hypoxemia. For both historical
groups, we selected three periods of 6 hours: after admis-




Time with no signal (%) 0.1 ± 0.2
Time with SIQ ≤ 0.3 (%) 0.1 ± 0.2
Time with hypoxemia (SpO2 ≤ 91%) (%) 1.7 ± 2.2
Time with normoxemia (SpO2 (92% to 96%)) (%) 96.7 ± 4.2
Time with hyperoxemia (SpO2 ≥ 97%) (%) 1.4 ± 2.1
SIQ, Signal Index Quality; SH, severely hypoxemic; MH, moderately hypoxemic.and the results are presented in Figures 2 and 3, which
illustrate the distribution of the time spent in the different
SpO2 ranges in the FiO2 controller group and in the
control groups. All comparisons between the study
group and both historical groups were significant,
showing a shorter time spent both in hyperoxemia and
in hypoxemia with the automatic FiO2 controller (see
Additional file 4: Table S4). In the historical group, a
slight decrease in hypoxemia (SpO2 ≤91%) and hyper-
oxemia (SpO2 ≥97%) periods was found after 7 days
after admission compared with the other two periods.each group according to the two controller profiles
poxemia group Moderate hypoxemia group
n = 10) (n = 10)
H-profile P value SH-profile MH-profile P value
0.1 ± 0.2 0.686 0.4 ± 0.5 0.1 ± 0.1 0.050
0.1 ± 0.2 1.000 0.3 ± 0.6 0.0 ± 0.0 0.072
1.9 ± 1.9 0.859 1.2 ± 1.0 1.0 ± 1.0 0.721
95.2 ± 4.8 0.047 95.1 ± 4.2 97.3 ± 2.8 0.074
2.8 ± 3.0 0.059 3.0 ± 3.0 1.6 ± 2.1 0.074
Figure 2 Percentages of time within the predefined SpO2 ranges during three periods (first 6 hours after admission, after 24 hours,
and after 7 days) in the historical group compared with the study group.
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The study showed that a specific open-loop FiO2 control-
ler is able to maintain SpO2 reliably within a predefined
target range. The time spent in the defined range is much
higher than in clinical practice, because of reduced time
both in hyperoxemia and in hypoxemia. Although differ-
ences between the two FiO2-SpO2 slopes of responses
are relatively small, each profile was well adapted to
each category of patients.
The historical group in our study, in accordance with
the literature, suggests that the situation of oxygenationFigure 3 Percentages of time within the predefined SpO2 ranges duri
and after 7 days) in the historical subgroup with a lower SpO2 threshcontrol can be improved. In ICUs, considerable variations
exist in the attitude toward oxygen management. A survey
among New Zealand and Australian intensivists showed
a large variation in practices [21]: for instance, for a
ventilated acute respiratory distress syndrome patient,
37% of respondents would not allow SaO2 of <85%
for ≤15 minutes, and 28% would not allow SaO2 <90%
for >24 hours. Hypoxemia is a major concern to clinicians,
whereas hyperoxemia is often left out of consideration. A
Canadian questionnaire study showed that most respon-
dents prevent much more hypoxemia than hyperoxemiang three periods (first 6 hours after admission, after 24 hours,
old at 92% compared with the study group.
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minimizing hyperoxemia, intensivists are simply guided
by reducing FiO2 to levels presumed to be nontoxic,
with little concern for PaO2 level.
Several recent clinical observations have, however, sug-
gested that liberal administration of oxygen can be toxic.
In an observational multicenter study concerning patients
admitted after resuscitation from cardiac arrest, those
exposed to hyperoxemia (PaO2 ≥300 mm Hg) experi-
enced increased mortality compared with both nor-
moxemic and hypoxemic groups (PaO2 <60 mm Hg) [2].
Administering supplemental oxygen to coronary heart dis-
ease (CHD) patients with the goal of maintaining 100%
saturation might result in vasoconstriction in the cor-
onary circulation and hemodynamic instability [3]. In a
general ICU population, both low PaO2 and high PaO2
during the first 24 hours after ICU admission were
associated with hospital mortality, forming a U-shaped
curve [1].
Another study found only an association between hyp-
oxemia and increased in-hospital mortality [23]. Recently,
Rachmale et al. [24] evaluated prospectively the electronic
medical record screening of 289 ICU patients with acute
lung injury to assess excessive oxygen exposure and its
effect on pulmonary outcomes. Excessive FiO2 was
defined as FiO2 >0.5, despite SpO2 >92%, and results
showed that 74% of the included patients were exposed
to it. The authors demonstrated a correlation between
prolonged FiO2 exposure and worsening of oxygenation
index at 48 hours and an association with longer dur-
ation of mechanical ventilation and ICU stay.
In our study, the potential of the automatic controller
is best shown with the comparison of the time spent in
hypoxemia with the historical subgroup. This subgroup
had a prescribed lower SpO2 threshold of 92%, but no
upper limitation. The FiO2 controller showed better re-
sults in preventing hypoxemia, at the same time, keeping
the time with hyperoxemia to a minimum and thus
maximizing time in normoxemia.
In accordance with current ICU practice, the monitoring
of oxygenation was based on pulse oximetry that continu-
ously and noninvasively measures SpO2. Pulse oximetry
has been shown to be a reliable technique for measuring
the oxygen level and reduces the frequency of blood gas
analysis [25-28]. Pulse oximetry has limitations, as, for
example, artifacts due to patient motion, and low perfu-
sion [29,30]. Among pulse-oximetry technologies, Signal
Extraction Technology, as used by Masimo, seems to
have superior performance compared with other pulse-
oximetry technologies in terms of motion and artifact,
false alarms, and data dropout [31-34]. In neonatology,
such technology has been shown helpful in reducing
severe retinopathy of prematurity in preterm infants
treated with supplemental oxygen [35].With the use of pulse oximetry and computer technol-
ogy, several attempts have been made to automatize the
adjustment of FiO2, especially in neonatology because of
the frequent and unpredictable change of oxygenation
and risks of hyperoxemia in premature babies [9-12,19,36].
This automation has rarely been proposed to adults to
guide the clinician to the most appropriate FiO2, apart
from research. A closed-loop control of oxygenation used
in military trauma patients demonstrated its efficiency at
reducing oxygen needs and showed that even severely
injured trauma patients can be managed with FiO2 <0.30
[37]. Rees et al. [38] created a decision support system
that provides advice about FiO2 setting, tidal volume,
and frequency rate based on physiological models. The
system has been tested retrospectively and prospectively
in a few patients to evaluate its ability to provide appropri-
ate FiO2 suggestions and has shown better FiO2 selection
in comparison with attending clinicians in intensive care
patients [39,40]. A system that automatically controls
oxygen administration during nasal oxygen therapy has
been proposed, based on SpO2 measurements [16]. A
fully controlled ventilation system was also compared
with usual care in a randomized controlled trial of
postoperative patients after cardiac surgery [18]. Both
ventilation and FiO2 were automatically controlled with a
target for SpO2 of 94% to 98%. The patients in the auto-
mated ventilation arm spent less time in nonacceptable
ventilation zones, but very few details were specifically
given concerning oxygenation.
We adapted an open-loop inspired oxygen control system
for use in adults that has been recently tested successfully
on intensive care neonates used in a closed-loop manner
[41]. We designed two profiles, with the hypothesis that the
more-hypoxemic patients, as defined by the lowest PaO2/
FiO2 ratio, would be less sensitive to FiO2 changes because
of intrapulmonary shunt. This was confirmed in the clinical
study, although the differences between the two slopes were
modest. A clinician could use the classic threshold of
200 mm Hg of PaO2/FiO2 ratio to select the best slope,
but if the other slope were to be selected, the results
would remain safe.
Limits of the study
First, the automated FiO2-controller prototype tested in
the present study presents some technologic limits be-
cause it depends on the reliability and the accuracy of
SpO2 and adjusts only the FiO2. It does not adjust the
PEEP level, for instance. Such a system must also contain
alarms alerting the clinician when consistent and sub-
stantial changes in FiO2 are observed; otherwise, a risk
would be to reduce the attentiveness of the caregiver and
delay recognition of changes in respiratory function.
These alarms were not specifically tested with the open
loop. We excluded patients with hemodynamic instability
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face any problem because of low signal-quality measure-
ment. The controller algorithm is also able to validate the
SpO2 signal quality and enters into a fall-back state, keep-
ing FiO2 constant. This condition must be investigated to
test the reliability of the system in extreme conditions.
Last, the experimental design gave us the unique oppor-
tunity to compare the system with usual care but could
not permit us to assess the workload reduction expected
with the automatic system. The 6-hour period tested in
the present study is relatively short. When we investigated
different time windows in the control group, however,
they all looked very similar, suggesting that these 6-
hour periods are meaningful and representative.
Conclusion
The tested open-loop system allowed maintaining SpO2
within a target range and decreased hyperoxemia and
hypoxemia periods in comparison with usual care. It could
provide physiological and clinical benefits to patients. As
with every automated system, it requires an understanding
of its operation and vigilance. This study opens the per-
spective for a test in a closed loop in comparison with
usual care.
Key messages
 An automated FiO2 controller based on
oxygen-saturation measurement is able to maintain
SpO2 reliably in a safety-predefined range during
mechanical ventilation of adult critically ill patients.
 The Automatic FiO2 controller exhibits excellent
performance in adjusting FiO2 at different levels of
baseline PaO2/FiO2 ratio.
 Automatic adjustment of FiO2 was able to maintain
SpO2 in a predefined target range much better
compared with a historical group of mechanically
ventilated patients.
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